Ethical barriers to perinatal mental health research and evidence-based treatment: An empirical study

AJOB Primary Research

Volumn 2, Issue 1, 2011, Pages 2-12

  Brandon, Anna R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Perinatal ethics; Perinatal mental health; Perinatal research; Pregnancy; Research

Indexed keywords

EID: 79956091150     PISSN: 21507716     EISSN: 21507724     Source Type: Journal    
DOI: 10.1080/21507716.2011.561517     Document Type: Article

References (70)

1. Abrams, S. M., T. Field, F. Scafidi, et al. 1995. Newborns of depressed mothers. Infant Mental Health Journal 16(3): 233-239.
2. ACOG Committee on Practice Bulletins-Obstetrics. 2008. ACOG Practice Bulletin: Clinical guidelines for obstetrician-gynecologists number 92, April 2008. Use of psychiatric medications during pregnancy and lactation. Obstetrics and Gynecology 111(4): 1001-1020.
3. Andrade, S., J. Gurwitz, R. L. Davis, et al. 2004. Prescription drug use in pregnancy. American Journal of Obstetrics&Gynecology 191(2): 398-407.
4. Arts, D. G., N. F. De Keizer, G. J. Scheffer, et al. 2002. Defining and improving data quality in medical registries: A literature review, case study, and generic framework. Journal of the American Medical Informatics Association 9(6): 600-611.
5. Beauchamp, T. L., and J. F. Childress. 2009. Principles of biomedical ethics. New York: Oxford University Press.
6. Bowlby, J. 1951. Maternal care and mental health. World Health Organization Monograph Series (2): 179.
7. Bulik, C. M., P. F. Sullivan, J. L. Fear, et al. 1999. Fertility and reproduction in women with anorexia nervosa: A controlled study. Journal of Clinical Psychiatry 60(2): 130-135; quiz 135-137.
8. Center for Drug Evaluation and Research. 1993. Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs. Washington, DC, July 22.
9. Centers for Disease Control and Prevention. 2008. Prevalence of self-reported postpartum depressive symptoms-17 States, 2004-2005. Morbidity and Mortality Weekly Report, April 9. Available at: http://www.cdc.gov/mmwR/preview/mmwrhtml/mm5714a1.htm (accessed June 15, 2010).
10. Centers for Disease Control and Prevention. 2009. Maternal and infant health research: Pregnancy complications. May 13. Available at: http://www.cdc.gov/reproductivehealth/maternalinfanthealth/PregComplications.htm (accessed June 15, 2010).
11. Charo, R. A. 1993. Protecting us to death: women, pregnancy, and clinical research trials. Saint Louis University Law Journal 38(1): 135-187.
12. Chervenak, F. A., and L. B. McCullough. 2009. Ethics of research in perinatal medicine. Seminars in Perinatology 33(6): 391-396.
13. Chung, T., T. K. Lau, A. Yip, et al. 2001. Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosomatic Medicine 63: 830-834.
14. Coverdale, J. H., L. B. McCullough, F. Chervenak, et al. 2008. The ethics of randomized placebo-controlled trials of antidepressants with pregnant women:Asystematic review. Obstetrics&Gynecology 112(6): 1361-1368.
15. Elton, C. 2010. A prenatal treatment raises questions of medical ethics. June 18. Available at: http://www.time.com/time/health/article/0,8599,1996453,00.html (accessed June 18, 2010).
16. Erwin, C. G. 2003. Embryonic stem cell research: One small step for science or one giant leap back for mankind? University of Illinois Law Review 2003: 211-262.
17. Field, T., M. Diego, J. Dieter, et al. 2004a. Prenatal depression effects on the fetus and the newborn. Infant Behavior & Development 27(2): 216-229.
18. Field, T., M. Diego, M. Hernandez-Reif, et al. 2004b. Prenatalmaternal biochemistry predicts neonatal biochemistry. International Journal of Neuroscience 114(8): 933-945.
19. Field, T., M. Diego, M. Hernandez-Reif, et al. 2006. Prenatal depression effects on the fetus and newborn: A review. Infant Behavior & Development 29: 445-455.
20. Finer, L. B., and S. K. Henshaw. 2006. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspectives on Sexual & Reproductive Health 38(2): 90-96.
21. Food and Drug Administration. 1979. Specific requirements on content and format of labeling for human prescription drugs. Fed. Reg. 44: 3734.
22. Food and Drug Administration. 1993. Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; Notice. Fed. Reg. 58: 39406-39416.
23. Food and Drug Administration. 2008. Content and format of labeling for human prescription drug and biological products; Requirements for pregnancy and lactation labeling. Fed. Reg. 73: 30831-30868.
24. Food and Drug Administration. 2009. Phases of an investigation. Title 21, Chapter 1, Part 312, Subpart B, Sec. 312.21 ed. Washington DC: Department of Health and Human Services, Food and Drug Administration.
25. Food and Drug Administration. 2010. List of pregnancy exposure registries. May 18. Available at: http://www.fda.gov/ScienceResearch/SpecialTopics/WomensHealthResearch/ucm134848.htm (accessed July 6, 2010).
26. Gaynes, B. N., N. Gavin, S. Meltzer-Brody, et al. 2005. Perinatal depression: Prevalence, screening accuracy and screening outcomes, 3-101. Rockville, MD: Agency for Healthcare Research and Quality.
27. Goodman, J. H. 2009. Women's attitudes, preferences, and perceived barriers to treatment for perinatal depression. Birth 36(1): 60-69.
28. Goodrum, L. A., G. D. V. Hankins, D. Jermain, et al. 2003. Conference report: Complex clinical, legal, and ethical issues of pregnant and postpartum women as subjects in clinical trials. Journal of Women's Health 12(9): 857-867.
29. Government Accounting Office. 2001. Women's health: Women sufficiently represented in new drug testing, but FDA oversight needs improvement. Washington DC: GAO.
30. Gruman, J. 1995. Introduction for superhighways for disease. Psychosomatic Medicine 57: 207.
31. Haire, D. 2001. FDA Approved obstetrics drugs: Their effects on mother and baby. Available at: http://nwhalliance.org/FDAAPPROVED.htm (accessed June 18, 2010).
32. Hernandez-Reif, M., T. Field, M. Diego, et al. 2006. Greater arousal and less attentiveness to face/voice stimuli by neonates of depressedmothers on the BrazeltonNeonatal Behavioral Assessment Scale. Infant Behavior & Development 29(4): 594-598.
33. Horrigan, T. J., A. V. Schroeder, R. M. Schaffer, et al. 2000. The triad of substance abuse, violence, and depression are interrelated in pregnancy. Journal of Substance Abuse Treatment 18(1): 55-58.
34. Jetter, A. 2009. Pregnant pause. Vogue May: 144-232.
35. Jones, N. A., T. Field, N. A. Fox, et al. 1998. Newborns of mothers with depressive symptoms are physiologically less developed. Infant Behavior and Development 21: 537-541.
36. Kass, N. E. 1996. Harms of excluding pregnant women fromclinical research: The case of HIV-infected pregnant women. Journal of Law, Medicine & Ethics 24: 36-46.
37. Kraepelin, E. 1904. Puerperal insanity. In Lectures on clinical psychiatry, ed. T. Johnstone, 129-139. New York:WilliamWood & Co.:
38. Kurki, T., V. Hiilesmaa, R. Raitasalo, et al. 2000. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstetrics and Gynecology 95(4): 487-490.
39. Lancaster, C. 2010. Pregnancy-associated violent death: Findings from the National Violent Death Reporting System. Richmond, VA: North American Society of Psychosocial Obstetrics and Gynecology.
40. Lancaster, C. A., K. J. Gold, H. A. Flynn, et al. 2010. Risk factors for depressive symptoms during pregnancy: A systematic review. American Journal of Obstetrics and Gynecology 202(1): 5-14.
41. Lobel, M., A. M. Yali, W. Zhu, et al. 2002. Beneficial associations between optimistic disposition and emotional distress in high-risk pregnancy. Psychology and Health 17(1): 77-95.
42. Lundy, B., N. A. Jones, T. Field, et al. 1999. Prenatal depression effects on neonates. Infant Behavior and Development 22: 119-129.
43. Lyerly, A. D., M. O. Little, and R. Faden. 2008. The second wave: Toward responsible inclusion of pregnant women in research. International Journal of FeministApproaches to Bioethics 1(2): 6-22.
44. MacDougall, V. L. 2002. Medical gender bias and managed care. Oklahoma City University Law Review 27: 781-910.
45. Macklin, R. 1990. Maternal-fetal conflict: An ethical analysis. Womens Health Issues 1(1): 28-30.
46. Macklin, R. 1993. Women's health: An ethical perspective. Journal of Law, Medicine & Ethics 21(1): 23-29.
47. Macklin, R. 1996. Ethics and reproductive health: a principled approach. World Health Statistics Quarterly-Rapport Trimestriel de Statistiques Sanitaires Mondiales 49(2): 148-153.
48. Macklin, R. 2010. Enrolling pregnant women in biomedical research. Lancet 375(9715): 632-633.
49. March of Dimes. 2010. Prematurity campaign. Available at: http://www.marchofdimes.com/mission/prematurity.html (accessed February 5, 2011).
50. Mastroianni, A. C., R. R. Faden, D. Federman, et al., eds. 1994. Women and health research: Ethical and legal issues of including women in clinical studies. Washington DC: National Academy Press.
51. Mattison, D., and A. Zajicek. 2006. Gaps in knowledge in treating pregnant women. Gender Medicine 3(3): 169-182.
52. Merkatz, R. B. 1993. Women in clinical trials: An introduction. Food & Drug Law Journal 48(2): 161-166.
53. Merkatz, R. B. 2007. Women's health at the FDA: Will it endure? Journal of Women's Health 16(6): 818-821.
54. Merkatz, R. B., and S. W. Junod. 1994. Historical background of changes in FDA policy on the study and evaluation of drugs in women. Academic Medicine 69(9): 703-707.
55. Meschke, L. L., and J. A. Holl. 2003. Assessing the risk of fetal alcohol syndrome: Understanding substance use among pregnant women. Neurotoxicology & Teratology 25(6): 667-674.
56. Mitchell, A. M., and C. M. Bulik. 2006. Eating disorders and women's health: An update. Journal of Midwifery & Women's Health 51(3): 193-201.
57. Newport, D. J., M. M. Wilcox, Z. N. Stowe, et al. 2002. Maternal depression: A child's first adverse life event. Seminars in Clinical Neuropsychiatry 7(2): 113-119.
58. Nicholson, W. K., R. Setse, F. Hill-Briggs, et al. 2006. Depressive symptoms and health-related quality of life in early pregnancy. Obstetrics & Gynecology 107(4): 798-806.
59. Orr, S. T., and S. A. James. 2002. Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland. American Journal of Epidemiology 156(9): 797-802.
60. OTIS. 2010. Organization of Teratology Information Specialists. Available at: http://www.otispregnancy.org (accessed July 7, 2010).
61. Penslar, R. L. n.d. IRB guidebook. Available at: http://www.hhs.gov/ohrp/irb/irbguidebook.htm (accessed July 15, 2010).
62. Schenker, J. G. 2003. Codes of perinatal ethics: An international perspective. Clinics in Perinatology 30(1): 45-65.
63. Shadigian, E., and S. T. Bauer. 2005. Pregnancy-associated death: A qualitative systematic review of homicide and suicide. Obstetrical & Gynecological Survey 60(3): 183-190.
64. US News and World Report. 2009. Research rankings best medical schools. Available at: http://grad-schools.usnews. rankingsandreviews. com/best-graduate-schools/top-medicalschools/research-rankings (accessed November 1, 2009).
65. U.S. Supreme Court. 1973. Jane Roe, et al. v. Henry Wade, District Attorney of Dallas County. 410 U.S. 113.
66. Van Den Bergh, B. R., M. Mennes, J. Oosterlaan, et al. 2005. High antenatal maternal anxiety is related to impulsivity during performance on cognitive tasks in 14-and 15-year-olds. Neuroscience and Biobehavioral Reviews 29(2): 259-269.
67. Wisner, K. L., P. S. Appelbaum, K. Uhl, et al. 2009. Pharmacotherapy for depressed pregnant women: Overcoming obstacles to gathering essential data. Clinical Pharmacology & Therapeutics 86(4): 362-365.
68. World Health Organization. 2001. Definitions and indicators in family planning, maternal & child health and reproductive health. Geneva: WHO.
69. Zhu, S. H., and A. Valbo. 2002. Depression and smoking during pregnancy. Addictive Behaviors 27(4): 649-658.
70. Zuckerman, B., H. Bauchner, S. Parker, et al. 1990. Maternal depressive symptoms during pregnancy, and newborn irritability. Journal of Developmental & Behavioral Pediatrics 11(4): 190-194.